Exodus Point Capital Management, LP Co Diagnostics, Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$3.76 - $6.29 $50,000 - $83,644	-13,298 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.03 - $9.61 $66,888 - $127,793	13,298 New	13,298 $82,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $484,157 - $736,593	-64,727 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $463,445 - $618,790	64,727 New	64,727 $534,000
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $176,346 - $397,608	-20,698 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $77,190 - $126,077	8,300 Added 66.95%	20,698 $192,000
Q3 2020 Nov 16, 2020	BUY	$8.24 - $30.8 $102,159 - $381,858	12,398 New	12,398 $168,000
Q2 2020 Aug 14, 2020	SELL	$7.46 - $23.42 $87,282 - $274,014	-11,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.91 - $17.81 $10,647 - $208,376	11,700 New	11,700 $89,000

4.23M

22.9K

30.4K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $42.2M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.